Correction of ATM gene function by aminoglycoside-induced read-through of premature termination codons. - Wikidata - wikimedia - TriplyDB

Correction of ATM gene function by aminoglycoside-induced read-through of premature termination codons.

Correction of ATM gene function by aminoglycoside-induced read-through of premature termination codons.

http://www.wikidata.org/entity/Q37595569

about

Reawakening retrocyclins: ancestral human defensins active against HIV-1 Aminoglycosides and other nonsense suppression therapies for the treatment of dystrophinopathy New approaches to treatment of primary immunodeficiencies: fixing mutations with chemicals Codon-biased translation can be regulated by wobble-base tRNA modification systems during cellular stress responses Therapeutic suppression of premature termination codons: mechanisms and clinical considerations (review)SMRT compounds correct nonsense mutations in primary immunodeficiency and other genetic models Antiviral activity of geneticin against dengue virus.ATM-dependent MiR-335 targets CtIP and modulates the DNA damage response Evaluation of Aminoglycoside and Non-Aminoglycoside Compounds for Stop-Codon Readthrough Therapy in Four Lysosomal Storage Diseases A novel porcine model of ataxia telangiectasia reproduces neurological features and motor deficits of human disease.The effect of gentamicin-induced readthrough on a novel premature termination codon of CD18 leukocyte adhesion deficiency patients.Aminoglycoside-Induced Premature Stop Codon Read-Through of Mucopolysaccharidosis Type I Patient Q70X and W402X Mutations in Cultured Cells.New trends in aminoglycosides use.Mass spectrometry-based tissue imaging of small molecules Rapid flow cytometry-based structural maintenance of chromosomes 1 (SMC1) phosphorylation assay for identification of ataxia-telangiectasia homozygotes and heterozygotes.Ataluren treatment of patients with nonsense mutation dystrophinopathy.Nonsense-mediated decay in genetic disease: friend or foe?SMRT compounds abrogate cellular phenotypes of ataxia telangiectasia in neural derivatives of patient-specific hiPSCs.A new series of small molecular weight compounds induce read through of all three types of nonsense mutations in the ATM gene.Making sense of nonsense GABA(A) receptor mutations associated with genetic epilepsies.Suppression of nonsense mutations as a therapeutic approach to treat genetic diseases.Functional characterization and targeted correction of ATM mutations identified in Japanese patients with ataxia-telangiectasia.Correction of prototypic ATM splicing mutations and aberrant ATM function with antisense morpholino oligonucleotides.A mouse model for nonsense mutation bypass therapy shows a dramatic multiday response to geneticin.Effect of Readthrough Treatment in Fibroblasts of Patients Affected by Lysosomal Diseases Caused by Premature Termination Codons Translational infidelity-induced protein stress results from a deficiency in Trm9-catalyzed tRNA modifications.Production of beta-globin and adult hemoglobin following G418 treatment of erythroid precursor cells from homozygous beta(0)39 thalassemia patients.Pharmacological read-through of nonsense ARSB mutations as a potential therapeutic approach for mucopolysaccharidosis VI Read-through compound 13 restores dystrophin expression and improves muscle function in the mdx mouse model for Duchenne muscular dystrophy A review of patents (2011-2015) towards combating resistance to and toxicity of aminoglycosides Translational read-through of a nonsense mutation causing Bartter syndrome.Readthrough of nonsense mutation W822X in the SCN5A gene can effectively restore expression of cardiac Na+ channels.Stably integrated luxCDABE for assessment of Salmonella invasion kinetics.Repair of UV photolesions in xeroderma pigmentosum group C cells induced by translational readthrough of premature termination codons.Nonaminoglycoside compounds induce readthrough of nonsense mutations.Ataluren as an agent for therapeutic nonsense suppression.Primary immunodeficiencies associated with DNA-repair disorders.Readthrough strategies for therapeutic suppression of nonsense mutations in inherited metabolic disease.Functional rescue of REP1 following treatment with PTC124 and novel derivative PTC-414 in human choroideremia fibroblasts and the nonsense-mediated zebrafish model.Small molecules as therapeutic agents for inborn errors of metabolism.

P2860

Q21145822-20B8FFAF-3476-4D46-B7D4-9673BA7F97C9 Q24240721-5C65162D-1CA5-48A7-BF5D-1689E2749D70 Q24656619-0B179D9F-2C5A-401C-9786-F2A24DEF4264 Q26829008-8F1234F8-A09C-4CEA-9893-5E8216CC39C3 Q26853614-DE09904E-9215-4E98-B805-042FB787F95F Q27007538-FD7A87D2-C55E-4670-89B2-97B16AC3876A Q27488716-11060BB0-87AF-471C-96EE-625B32777396 Q28488177-FCB9ED36-DF1F-454B-8423-85A5672B90A9 Q28547356-56AA2B94-8D38-4E02-A3D3-7B2DD6E9BD0D Q30670040-61A09848-084B-4FC3-AD6F-01EC07899B25 Q33754791-941BC473-7D39-44E2-93FC-A582B153EB71 Q33947357-C908E152-27CA-46B8-BFFD-1283732D2A0D Q33951177-CB3C5ECF-6EA7-43EE-91B9-DA3CC5E0B04C Q34279939-8130D446-B08D-4370-8759-78A56BFA7E51 Q34307085-57304A27-D67B-46FF-AD97-48A2BE884D49 Q34561960-A8CAB76D-9026-4F78-9A51-8EF877416B74 Q34658988-815C9D55-B83C-418F-9279-20FF99929B98 Q34709237-7BD8F5F8-14B4-434E-8820-42780B47D6B1 Q34775214-342118E8-3C3A-4D78-82D2-C87943CFC6D1 Q34789999-5C697857-39F3-48AB-8A1D-81B588C47EB1 Q35287888-2EE83005-E941-4F05-9DE9-25C3C235949C Q35681880-F3D4655F-EE76-44E3-9AB7-CA97FBED3BC0 Q35699768-AF028317-4D2B-40E0-B459-DCE82306B86E Q36024071-164028DD-C158-4057-AA37-A7B2118347A4 Q36157628-0A46B1D4-169A-4DE0-911A-5D8A0A87F17F Q36391935-03563D3D-71AB-4C8C-84AC-05C0C8F3D039 Q36611332-E148BA91-B089-4D47-8CC3-81DEA3A6646D Q36662823-C2656F79-A551-4FB5-AC8D-F6EF6080C4FE Q36714202-8896214B-C799-473D-AA36-C57FB0B36023 Q36726249-0B39FA84-9AE4-46DA-94E4-0707358822D4 Q36917134-3193BAA7-D076-465D-AE4D-F94E6DA1C9EF Q37258745-060CB3F2-6932-486C-95DF-FB41A550CB97 Q37345435-90974450-6E76-4E35-8A6C-893CD2902810 Q37353126-C66C35DA-7BED-4415-811C-CE9871601D0B Q37377461-8A5057EA-3010-4A03-92E4-3EC798EF8A5D Q37670599-6D4A68DC-9471-47DA-8EBA-63FC46CA0CCB Q37713997-A6E6A8B7-E453-4413-8008-1227F6681968 Q38072030-BC43C2D8-0AEC-4F99-866B-8B2473903400 Q38762930-F378731D-60A0-43BE-A429-2C2AE8A61ABB Q39038060-36D33A29-AB77-42D2-8624-26E996F9EACB

P2860

Correction of ATM gene function by aminoglycoside-induced read-through of premature termination codons.

http://www.wikidata.org/entity/Q37595569

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 21 October 2004

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Correction of ATM gene functio ...... premature termination codons.

@en

Correction of ATM gene functio ...... premature termination codons.

@nl

type

label

Correction of ATM gene functio ...... premature termination codons.

@en

Correction of ATM gene functio ...... premature termination codons.

@nl

prefLabel

Correction of ATM gene functio ...... premature termination codons.

@en

Correction of ATM gene functio ...... premature termination codons.

@nl

P1433

Q37595569-9054B222-61BE-474A-8E62-1607D8B95267

P1476

Q37595569-FD49A99E-D733-4C2F-B358-BA47D2B798D4

P2093

Q37595569-1989178B-6AC1-411A-A4E3-E74634FA7D23

Q37595569-27DA0E5E-C8DC-47B2-B428-A71972E9CA64

Q37595569-706CD4E0-F281-4C11-8579-5393FEA4F2AC

Q37595569-79BCF9D2-9907-4029-854F-51A643A57A99

Q37595569-8B6FD26A-C79B-496C-969F-158ACE77F37F

Q37595569-BF698126-E2D6-42CA-A39E-E35D8102C06C

Q37595569-D6CF10F4-1887-4F80-ABB0-E7E77FDDD10B

P2860

Q37595569-079192ED-4D31-4349-898F-FEA61DF437ED

Q37595569-0C488F06-B5D9-42CE-9090-600FCA3A0528

Q37595569-0E84E6DF-173D-4E1D-ACCC-F36ECCD0A38D

Q37595569-0F72EBEA-2620-42F1-9852-7EBDE287417E

Q37595569-11D4DBF6-6D6C-4DB0-95DD-1139DE19BCEA

Q37595569-235BEA97-572F-47BE-A827-A4A71A0A74C9

Q37595569-24DEE6EC-47A2-4A2D-8776-DD93E3AEF1F5

Q37595569-374F3635-7D01-4962-9896-090C55C4CA8B

Q37595569-377D8AC4-E46D-4403-9D5E-B5388FE5E554

Q37595569-38008861-61F5-46F5-88A0-F2C307CB363B

P304

Q37595569-68660C95-6070-4870-B9BA-CD45C9DDF731

P31

Q37595569-F3A95823-DE27-4D23-9055-044E418DDF93

P356

Q37595569-792E6C77-C8C8-4DCE-AECF-896B379FBBBD

P407

Q37595569-63B2A0ED-F3F6-4299-8FA6-9AEEAB0B8C97

P433

Q37595569-FC9B9B2E-C3C9-4F92-B4BE-06592CF0DC8C

P478

Q37595569-E2593479-0604-434B-B911-A5BDBF0BE09A

P577

Q37595569-5B636115-55D9-446C-BE4F-DF3DAF416A3F

P5875

Q37595569-142C0024-895A-4B84-A6DE-5F4F65A298B6

P698

Q37595569-3D2F3329-2DB7-4306-8F7E-EA49E84CED44

P932

Q37595569-FDBEB03D-D026-4AFB-803B-E0B7B6188D7C

P356

PNAS.0405155101

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

Correction of ATM gene functio ...... premature termination codons.

@en

P2093

Chih-Hung Lai

http://www.w3.org/2001/XMLSchema#string

Helen H Chun

http://www.w3.org/2001/XMLSchema#string

Kristin M Gamo

http://www.w3.org/2001/XMLSchema#string

Liutao Du

http://www.w3.org/2001/XMLSchema#string

Midori Mitui

http://www.w3.org/2001/XMLSchema#string

Richard A Gatti

http://www.w3.org/2001/XMLSchema#string

Shareef A Nahas

http://www.w3.org/2001/XMLSchema#string

P2860

Expression of CTNS alleles: subcellular localization and aminoglycoside correction in vitro

Crystal structure of geneticin bound to a bacterial 16S ribosomal RNA A site oligonucleotide

DNA damage activates ATM through intermolecular autophosphorylation and dimer dissociation

Modulation of RNA function by aminoglycoside antibiotics.

Aminoglycoside antibiotics restore dystrophin function to skeletal muscles of mdx mice

Gentamicin-induced correction of CFTR function in patients with cystic fibrosis and CFTR stop mutations.

Improved diagnostic testing for ataxia-telangiectasia by immunoblotting of nuclear lysates for ATM protein expression.

Aminoglycoside antibiotics mediate context-dependent suppression of termination codons in a mammalian translation system

Ataxia-telangiectasia: diagnosis and treatment.

Ataxia-telangiectasia: mutations in ATM cDNA detected by protein-truncation screening

P304

15676-15681

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1073/PNAS.0405155101

http://www.w3.org/2001/XMLSchema#string

P407

P433

44

http://www.w3.org/2001/XMLSchema#string

P478

101

http://www.w3.org/2001/XMLSchema#string

P577

2004-10-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

8218031

http://www.w3.org/2001/XMLSchema#string

P698

15498871

http://www.w3.org/2001/XMLSchema#string

P932

524838

http://www.w3.org/2001/XMLSchema#string